Statistics
Publications
43
Citations
7.9K
H-Index
28
Active since
1994
Philip Friedlander is an author at Icahn School of Medicine at Mount Sinai specializing in oncology, medicine, and immunotherapy.
Publications per year
1994–2025
43
43
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
Aleksandar Sekulić, Michael R. Migden, Anthony E. Oro et al. · New England Journal of Medicine · 2012 · 1.4K citations · Full text
Medicine, Oncology, Pharmacology +17
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
Paul Nghiem, Shailender Bhatia, Evan J. Lipson et al. · New England Journal of Medicine · 2016 · 1.2K citations · Full text
Medicine, Dermatology, Oncology +17
Jason Chesney, Igor Puzanov, Frances A. Collichio et al. · Journal of Clinical Oncology · 2017 · 617 citations
Medicine, Oncology, Pharmacotherapy +17
Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Donald P. Lawrence, Cecilia Lezcano et al. · Cancer Immunology Research · 2014 · 604 citations · Full text
Pharmacy, Immunology, Pharmacology +16
F. Stephen Hodi, Christopher L. Corless, Anita Giobbie‐Hurder et al. · Journal of Clinical Oncology · 2013 · 595 citations · Full text
Medicine, Dermatology, Oncology +17
1–5 of 43